Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shareen Nelson

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|August 17, 2021
Striatal Cholinergic Dysregulation after Neonatal Decrease in X-Linked Dystonia Parkinsonism-Related TAF1 IsoformsMaria-Daniela Cirnaru, Jordi Creus-Muncunill, Shareen Nelson, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALSDefne A Amado, Ashley B Robbins, Alicia R Smith, et al.
Nature Communications|June 25, 2025
AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 miceDefne A Amado, Ashley B Robbins, Katherine R Whiteman, et al.
Nature Communications|October 23, 2025
Author Correction: AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 miceDefne A Amado, Ashley B Robbins, Katherine R Whiteman, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Movement Disorders : Official Journal of the Movement Disorder Society|August 17, 2021
Striatal Cholinergic Dysregulation after Neonatal Decrease in X-Linked Dystonia Parkinsonism-Related TAF1 IsoformsMaria-Daniela Cirnaru, Jordi Creus-Muncunill, Shareen Nelson, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALSDefne A Amado, Ashley B Robbins, Alicia R Smith, et al.
Nature Communications|June 25, 2025
AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 miceDefne A Amado, Ashley B Robbins, Katherine R Whiteman, et al.
Nature Communications|October 23, 2025
Author Correction: AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 miceDefne A Amado, Ashley B Robbins, Katherine R Whiteman, et al.
Pageof 1